Chiron Corporation

The Chiron Corporation was an internationally oriented American biotechnology company based in Emeryville, California, which was acquired by Novartis on April 20, 2006.

The Chiron Corporation was founded in 1981 by William Rutter, Edward Penhoet and Pablo Valenzuela and 1983 on the stock exchange. The first profit the company could boast 1990. In 1991, the Cetus Corporation was acquired for 660 million U.S. dollars. This was the largest ever acquisition of a biotechnology company Cetus Corp. represents the. had aldesleukin ( interleukin -2, proleukin ®), which in 1998 was given in 1992 by the Food and Drug Administration (FDA ) marketing approval for the treatment of metastatic kidney cancer, and the treatment of metastatic melanoma. Chiron acquired 1995 Iolab Division of Johnson & Johnson and the Viagene Inc. of San Diego, 1996 Impfsparte Behringwerke.

In 1997, Chiron sold his business Ophthalmika to Bausch & Lomb in 1998 Chiron Diagnostics Division of Bayer AG. In 1994 it came to the cooperation between the Swiss Ciba -Geigy, which took 49.9 percent of the shares. With the merger of Ciba and Sandoz to form Novartis in 1996 their share fell to Chiron Corporation to 44 percent. End of 2005, Novartis announced that for $ 45 per share, or a total amount of 5.1 billion U.S. dollars to take over Chiron completely.